Best of ASH 2016
Dr. Brian G.M. Durie discusses key takeaways from the American Society of Hematology annual conference and explains how this new and important information relates to myeloma patients, caregivers, and other members of the myeloma community.
|
This teleconference is sponsored by an educational grant from:
Amgen, Celgene Corporation, Janssen, and Takeda Oncology
Previous Post
Is MGUS always asymptomatic?
Next Post
IMWG: Who should be treated?